Close
Nordic 9Nordic 9

aMoon (investor - Venture Capital)

Israel amoon.fund
See something wrong or missing? Let us know
Offices:Tel Aviv

aMoon is an Israel-based healthtech and life sciences venture fund operated by Marius Nacht.

Average round investment:59.55M USD
Average number per year:1.7
Distribution: 2025 (1)2024 (2)2020 (2)
Portfolio companies: France AdcytherixSwitzerland LyfegenGermany CPTx See the entire list
Mostly invests in: Switzerland Switzerland (2) Health services (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to aMoon

Name Criteria
Japan Mitsubishi Corp
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
South Korea Korea Investment Partners
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: France, United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Netherlands Partners in Equity
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services, Pharma, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: France, Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland Korify Capital
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Pharma, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Switzerland, Germany, United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Lauxera Capital Partners
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Pharma, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: France, Germany, United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Eclipse Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Switzerland, France, United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Canada Georgian
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Germany Leaps by Bayer
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Heroic Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: France, Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
China Hillhouse Capital Group
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Top